Free Trial
NASDAQ:WGS

GeneDx Q1 2025 Earnings Report

GeneDx logo
$95.47 -2.81 (-2.86%)
Closing price 04/17/2025 04:00 PM Eastern
Extended Trading
$97.96 +2.49 (+2.61%)
As of 04/17/2025 05:52 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

GeneDx EPS Results

Actual EPS
N/A
Consensus EPS
$0.11
Beat/Miss
N/A
One Year Ago EPS
N/A

GeneDx Revenue Results

Actual Revenue
N/A
Expected Revenue
$79.90 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

GeneDx Announcement Details

Quarter
Q1 2025
Time
Before Market Opens
Conference Call Date
Wednesday, April 30, 2025
Conference Call Time
8:30AM ET

Conference Call Resources

GeneDx Earnings Headlines

GeneDx Holdings Corp. (WGS) Rose on Robust Customer Demand
Craig-Hallum Sticks to Their Buy Rating for GeneDx Holdings (WGS)
Crypto’s crashing…but we’re still profiting
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess. The news is screaming fear. But while most traders watch their portfolios tank…
GeneDx to acquire Fabric Genomics for $33M in cash at closing
Brokerages Set GeneDx Holdings Corp. (NASDAQ:WGS) PT at $72.33
See More GeneDx Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like GeneDx? Sign up for Earnings360's daily newsletter to receive timely earnings updates on GeneDx and other key companies, straight to your email.

About GeneDx

GeneDx (NASDAQ:WGS), through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.

View GeneDx Profile

More Earnings Resources from MarketBeat